Why the study?
No studies had compared the clinical and economic burden of chronic HFrEF following a worsening heart failure event versus stable disease to inform healthcare decision makers.
Does a worsening heart failure event increase health care resource use and costs in patients with chronic HFrEF?
Does a worsening heart failure event increase health care resource use and costs in patients with chronic HFrEF?
A worsening heart failure event in patients with chronic HFrEF is associated with significantly increased subsequent healthcare resource utilization and costs compared to stable disease.
Answers are grounded in this paper and cite their sources.
Higher post-WHFE HCRU and costs in HFrEF warrant closer monitoring; leaves open whether targeted interventions reduce burden in observational cohorts.
INTRODUCTION: A worsening heart failure event (WHFE) is defined as progressively escalating heart failure signs/symptoms requiring intravenous diuretic treatment or hospitalization. No studies have compared the burden of chronic heart failure with reduced ejection fraction (HFrEF) following a WHFE versus stable disease to inform healthcare decision makers. METHODS: Commercial Database included patients younger than 65 years of age with HFrEF (one inpatient or two outpatient claims of systolic HF or one outpatient claim of systolic HF plus one outpatient claim of any HF). The first claim for HFrEF during 2016 was the index date. Patients were followed for the first 12 months after the index date (the worsening assessment period) to identify a WHFE, and for an additional 12 months or until the end of continuous enrollment (the post-worsening assessment period). Mean per patient per month (PPPM) health care resource use (HCRU) and costs were compared between patients following a WHFE and stable patients during the two periods using generalized linear models adjusting for patient characteristics. RESULTS: Of 16,646 patients with chronic HFrEF, 26.8% developed a WHFE. Adjusted all-cause hospitalizations (0.16 vs. 0.02 PPPM, P < 0.0001), outpatient visits (3.54 vs. 2.73 PPPM, P < 0.0001), and emergency department visits (0.25 vs. 0.06 PPPM, P < 0.0001) were higher in patients following a WHFE than stable patients during the worsening assessment period. Similar differences in HCRU were observed between the two cohorts during the post-worsening assessment period. Mean total adjusted cost of care PPPM was $8657 in patients with HFrEF following a WHFE versus $2195 in stable patients during the worsening assessment period, and $6809 versus $2849, respectively, during the post-worsening assessment period. CONCLUSION: HCRU and costs were significantly greater in patients with chronic HFrEF following a WHFE compared to those who remained stable, suggesting an unmet need to improve clinical and economic outcomes among these patients.
No takes yet. Share an insight, caveat, or question.
Butler et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: